Endometrial cancer tissue and sample bank with pathology and metabolomics support
Core 2: Biospecimen, Metabolomics, and Pathology Core
This program will build a shared collection of tumor tissue, blood, and clinical information plus expert pathology and metabolic testing to help research on endometrial cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11191552 on NIH RePORTER |
What this research studies
As a patient, you could be asked to consent to donate tumor tissue, blood, or other samples when you are diagnosed with or have a recurrence of endometrial cancer at a participating site. Your samples will be processed using validated methods, stored in a federated biobank across the partner institutions, and linked to clinical data so results are comparable. The core offers centralized expert pathology review and access to a specialized metabolomics center to generate high-quality molecular data. De-identified samples and data will be shared with approved SPORE projects and researchers to accelerate discoveries for endometrial cancer.
Who could benefit from this research
Good fit: Ideal candidates are people with new or recurrent endometrial cancer treated at one of the participating institutions who can consent to provide tissue or blood samples.
Not a fit: People without endometrial cancer, those treated outside the participating sites, or individuals unable or unwilling to provide consent or usable samples may not directly benefit from this project.
Why it matters
Potential benefit: If successful, this resource could help researchers discover better diagnostic markers, treatment targets, or ways to predict who will respond to specific therapies for endometrial cancer.
How similar studies have performed: Other tumor biobanks and metabolomics initiatives have supported important cancer discoveries, so this effort builds on established and successful approaches.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Hagemann, Ian S. — Washington University
- Study coordinator: Hagemann, Ian S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.